glp 1 analogues side effects Part 2 of a 3-Part Series; GLP-1 Medications for Weight Loss Clinical Recommendations to Manage Gastrointestinal

11 Exenatide has been associated with hypoglycemia when given in combination with metformin, SUs, and TZDs

Because compounded injections are not FDA approved, there is increased variability and risk

A greater sweet taste intensity was reported by 19.4% of the Wegovy group, 21.6% of the Ozempic group and 21.7% of the Mounjaro group

What the Evidence Actually Shows The efficacy signal for semaglutide in weight management is unusually strong for pharmacology, and it is worth being precise about what kind of evidence it is

To date, no desensitization protocol with GLP-1 receptor agonists has been reported

It enhances lipid metabolism and facilitates the utilization and clearance of fats